Skip to main content
Premium Trial:

Request an Annual Quote

Vitro and PhosphoSolutions Collaborate to Study Stem Cell Proteomics

NEW YORK, Jan. 12 (GenomeWeb News) - Vitro Diagnostics and PhosphoSolutions will collaborate on stem cell research, Vitro Diagnostics said today.


The collaboration aims to investigate intracellular signaling mechanisms involved with regulation of stem cell growth and differentiation.


Early investigations by Vitro and PhosphoSolutions provided evidence suggesting interaction between key regulatory pathways through phosphorylation.


Vitro has developed methodologies to induce differentiation of functional human beta cells from adult pancreatic stem cell lines. PhosphoSolutions makes antibodies which can discriminate a target protein based on its phosphorylation state.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.